baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Codexis Inc/ US1920051067 /

2024-05-14 5:42:14 PM	Chg. +0.0450	Volume	Bid2024-05-14	Ask2024-05-14	High	Low
3.6550USD	+1.25%	323,365 Turnover: 780,280.3935	3.6500Bid Size: 500	3.6600Ask Size: 300	3.7200	3.5705

GlobeNewswire 12:00 PM Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting

GlobeNewswire 05-06 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...

GlobeNewswire 05-02 Codexis Reports First Quarter 2024 Financial Results

GlobeNewswire 04-18 Codexis to Report First Quarter 2024 Financial Results on May 2

GlobeNewswire 04-11 Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board

GlobeNewswire 02-28 Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results

GlobeNewswire 02-26 Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Ro...

GlobeNewswire 02-26 Codexis to Participate in TD Cowen 44th Annual Health Care Conference

GlobeNewswire 02-20 Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board

GlobeNewswire 02-14 Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28

GlobeNewswire 02-13 Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further S...

GlobeNewswire 02-01 seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT Genera...

GlobeNewswire 2023-12-27 Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108

GlobeNewswire 2023-12-13 Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA Polymerase

GlobeNewswire 2023-12-13 Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform

GlobeNewswire 2023-12-11 Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeuti...

GlobeNewswire 2023-11-28 Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics...

GlobeNewswire 2023-11-14 Codexis to Participate in 35th Annual Piper Sandler Healthcare Conference

GlobeNewswire 2023-11-03 INVESTOR ALERT: Abbott Cooper PLLC Announces Investigation into Codexis, Inc.; Urges Codexis Stockho...

GlobeNewswire 2023-11-02 Codexis Reports Third Quarter 2023 Financial Results

GlobeNewswire 2023-10-31 Codexis to Participate in Upcoming Healthcare Conferences

GlobeNewswire 2023-10-27 Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe

GlobeNewswire 2023-10-26 Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe

GlobeNewswire 2023-10-19 Codexis to Report Third Quarter 2023 Financial Results on November 2

GlobeNewswire 2023-09-29 Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award

Codexis Inc/ US1920051067 /

If you wish to receive reply to your feedback, please provide your email address.